Absence of amplification of HER-2/neu (c-erbB-2) gene in Ewing's Sarcoma: A real-time polymerase chain reaction method

Pathology Research and Practice

Volumn 200, Issue 10, 2004, Pages 663-667

  Kim, Gou Young ^a   Park, Jae Hoon ^b   Kim, Youn Wha ^b   Jung, Woon Won ^c   Unni, K Krishnan ^d   Park, Yong Koo ^b  

^a Gachon University College of Medicine   (South Korea)

^b Kyung Hee University Hospital   (South Korea)

^c MyGene Company   (South Korea)

^d MAYO CLINIC   (United States)

Author keywords

ErbB 2; Ewing's sarcoma; Polymerase chain reaction; Prognosis

Indexed keywords

BETA GLOBIN; DNA; EPIDERMAL GROWTH FACTOR RECEPTOR 2; PARAFFIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA ISOLATION; EWING SARCOMA; GENE AMPLIFICATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; POLYMERASE CHAIN REACTION; PROGNOSIS; QUANTITATIVE ANALYSIS;

EID: 10244260506     PISSN: 03440338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prp.2004.08.002     Document Type: Article

References (24)

1. G. Amir J. Issakov I. Meller E. Sucher A. Peyser I.J. Cohen I. Yaniv M.W. Ben Arush U. Tavori Y. Kollender N. Ron N. Peylan-Ramu Expression of p53 gene product and cell proliferation marker Ki-67 in Ewing's sarcoma: Correlation with clinical outcome Hum. Pathol. 33 2002 170-174
2. A. Bankfalvi R. Simon B. Brandt H. Burger I. Vollmer B. Dockhorn-Dworniczak R.J. Lelle W. Boecker Comparative methodological analysis of erbB-2/HER-2 gene dosage, chromosomal copy number and protein overexpression in breast carcinoma tissues for diagnostic use Histopathology 37 2000 411-419
3. I. Bieche M. Olivi M.H. Champeme D. Vidaud R. Lidereau M. Vidaud Novel approach to quantitative polymerase chain reaction using real-time detection: Application to the detection of gene amplification in breast cancer Int. J. Cancer 78 1998 661-666
4. P.F. Bongiorno R.I. Whyte E.J. Lesser J.H. Moore M.B. Orringer D.G. Beer Alterations of K-ras p53 and erbB-/2neu in human lung adenocarcinomas J. Thorac. Cardiovasc. Surg. 107 1994 590-595
5. F.D. Cirisano B.Y. Karlan The role of the HER-2/neu oncogene in gynecologic cancers J. Soc. Gynecol. Investig. 3 1996 99-105
6. M. Cuello S.A. Ettenberg A.S. Clark M.M. Keane R.H. Nau P.A. Dennis S. Lipkowitz Down-regulation of the erbB-2 receptor by trastuzumab (herceptin) enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB-2 Cancer Res. 61 2001 4892-4900
7. E. George G.A. Niehans P.E. Swanson J.G. Strickler T.P. Singleton Overexpression of the c-erbB-2 oncogene in sarcomas and small round-cell tumors of childhood. An immunohistochemical investigation Arch. Pathol. Lab. Med. 116 1992 1033-1035
8. C.A. Heid J. Stevens K.J. Livak P.M. Williams Real time quantitative PCR Genome Res. 6 1996 986-994
9. U. Lehmann S. Glockner W. Kleeberger H.F. von Wasielewski H. Kreipe Detection of gene amplification in archival breast cancer specimens by laser-assisted microdissection and quantitative real-time polymerase chain reaction Am. J. Pathol. 156 2000 1855-1864
10. E. Lyon A. Millson M.C. Lowery R. Woods C.T. Wittwer Quantification of HER2/neu gene amplification by competitive pcr using fluorescent melting curve analysis Clin. Chem. 47 2001 844-851
11. H. Meden A. Beneke T. Hesse I. Novophashenny M. Wischnewsky Weekly intravenous recombinant humanized anti-P185HER2 monoclonal antibody (herceptin) plus docetaxel in patients with metastatic breast cancer: A pilot study Anticancer Res. 21 2001 1301-1305
12. P.G. Natali M.R. Nicotra A. Bigotti I. Venturo D.J. Slamon B.M. Fendly A. Ullrich Expression of the p185 encoded by HER2 oncogene in normal and transformed human tissues Int. J. Cancer 45 1990 457-461
13. G. Pauletti W. Godolphin M.F. Press D.J. Slamon Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization Oncogene 13 1996 63-72
14. P.C. Roche J.N. Ingle Increased HER2 with U.S. Food and Drug Administration-approved Antibody J. Clin. Oncol. 17 1999 434
15. C. Shih L.C. Padhy M. Murray R.A. Weinberg Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts Nature 290 1981 261-264
16. D.J. Slamon G.M. Clark S.G. Wong W.J. Levin A. Ullrich W.L. McGuire Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene Science 235 1987 177-182
17. P. Terrier A. Llombart-Bosch G. Contesso Small round blue cell tumors in bone: Prognostic factors correlated to Ewing's sarcoma and neuroectodermal tumors Semin. Diagn. Pathol. 13 1996 250-257
18. D.G. Thomas T.J. Giordano D. Sanders J.S. Biermann L. Baker Absence of HER2/neu gene expression in osteosarcoma and skeletal Ewing's sarcoma Clin. Cancer Res. 8 2002 788-793
19. C.M. Tsai D. Yu K.T. Chang L.H. Wu R.P. Perng N.K. Ibrahim M.C. Hung Enhanced chemoresistance by elevation of p185neu levels in HER-2/neu-transfected human lung cancer cells J. Natl. Cancer Inst. 87 1995 682-684
20. S. Wang M.H. Saboorian E. Frenkel L. Hynan S.T. Gokaslan R. Ashfaq Laboratory assessment of the status of Her-2/neu protein and oncogene in breast cancer specimens: Comparison of immunohistochemistry assay with fluorescence in situ hybridisation assays J. Clin. Pathol. 53 2000 374-381
21. D. Ye A. Maitra C.F. Timmons P.J. Leavey R. Ashfaq R.L. Ilaria Jr. The epidermal growth factor receptor HER2 is not a major therapeutic target in Ewing sarcoma J. Pediatr. Hematol. Oncol. 25 2003 459-466
22. D. Yu B. Liu M. Tan J. Li S.S. Wang M.C. Hung Overexpression of c-erbB-2/neu in breast cancer cells confers increased resistance to Taxol via mdr-1-independent mechanisms Oncogene 13 1996 1359-1365
23. D. Yu T.C. Suen D.H. Yan L.S. Chang M.C. Hung Transcriptional repression of the neu protooncogene by the adenovirus 5 E1A gene products Proc. Natl. Acad. Sci. USA 87 1990 4499-4503
24. Z. Zhou S.F. Jia M.C. Hung E.S. Kleinerman E1A sensitizes HER2/neu-overexpressing Ewing's sarcoma cells to topoisomerase II-targeting anticancer drugs Cancer Res. 61 2001 3394-3398